| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Axcan Pharma Inc. > News item |
Axcan, TPG deal granted early termination of HSR waiting period
By Lisa Kerner
Charlotte, N.C., Jan. 7 - The Federal Trade Commission granted early termination of the Hart-Scott-Rodino waiting period in the proposed acquisition of Axcan Pharma, Inc. by TPG Capital.
Axcan shareholders are set to vote on the arrangement on Jan. 25.
As previously reported, Axcan agreed to be acquired by TPG and its affiliates in an all-cash transaction valued at some $1.3 billion, or $23.35 per common share.
Axcan is a Mont-Saint-Hilaire, Quebec, specialty pharmaceutical company.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.